BerandaAMRN • NASDAQ
add
Amarin Corporation PLC
Tutup sebelumnya
$9,36
Rentang hari
$8,84 - $9,34
Rentang tahun
$7,08 - $20,60
Kapitalisasi pasar
182,40Â jt USD
Volume Rata-Rata
123,10Â rb
Dalam berita
Keuangan
Laporan Pendapatan
Pendapatan
Laba bersih
| (USD) | Des 2024info | Perubahan Y/Y |
|---|---|---|
Pendapatan | 62,31Â jt | -16,61% |
Biaya operasional | 42,96Â jt | -13,63% |
Laba bersih | -48,62Â jt | -741,00% |
Margin laba bersih | -78,03 | -908,14% |
Penghasilan per saham | -0,40 | — |
EBITDA | -15,31Â jt | -295,22% |
Tarif pajak efektif | 2,58% | — |
Neraca
Total aset
Total liabilitas
| (USD) | Des 2024info | Perubahan Y/Y |
|---|---|---|
Investasi tunai jangka pdk | 294,22Â jt | -8,25% |
Total aset | 685,35Â jt | -17,60% |
Total liabilitas | 199,17Â jt | -28,76% |
Total ekuitas | 486,18 jt | — |
Saham yang beredar | 20,71 jt | — |
Harga terhadap nilai buku | 0,40 | — |
Tingkat pengembalian aset | -5,59% | — |
Tingkat pengembalian modal | -7,75% | — |
Arus Kas
Perubahan kas bersih
| (USD) | Des 2024info | Perubahan Y/Y |
|---|---|---|
Laba bersih | -48,62Â jt | -741,00% |
Kas dari operasi | -13,31Â jt | -1.963,57% |
Kas dari investasi | -22,84Â jt | 67,83% |
Kas dari pembiayaan | 17,00Â rb | -79,52% |
Perubahan kas bersih | -36,13Â jt | 49,51% |
Arus kas bebas | 13,85Â jt | 215,08% |
Tentang
Amarin Corporation is an Irish-American biopharmaceutical company founded in 1993 and headquartered in Dublin, Ireland and Bridgewater, New Jersey. The company develops and markets medicines for the treatment of cardiovascular disease. It has developed the drug Vascepa, a prescription grade omega-3 fatty acid.
In July 2012, their lead-candidate drug named Vascepa received FDA-approval, competing against GlaxoSmithKline's Lovaza. Wikipedia
Didirikan
1 Mar 1989
Kantor pusat
Situs
Karyawan
275
